In the EU/EEA, increased circulation of SARS-CoV-2 is observed, with limited impact on hospitalisations. Respiratory syncytial virus and influenza circulation remain at low levels. 

This issue of the Communicable disease threats report (CDTR) covers the period 3 – 9October 2026, and includes updates on respiratory virus epidemiology in the

This issue of the Communicable disease threats report (CDTR) covers the period 26 September – 2 October 2026, and includes updates on Crimean Congo haemorrhagic

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-25 September, and includes updates on respiratory virus epidemiology in the EU/EEA

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 12-18 September, and includes updates on Ebola, malaria, botulism, avian influenza A(H9N2),

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5 -12 September, and includes updates on Ebola, an overview of respiratory

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 29 August – 4 September, and includes updates on Ebola, SARS-CoV-2 variant

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 22 – 28 August, and includes updates on diphtheria, Ebola, swine influenza

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 15-21 August 2026, and includes updates on Ebola, respiratory virus epidemiology in

This document is the main module of a suite of documents that together comprise guidance for integrated respiratory virus surveillance in the EU/EEA.

Today ECDC published new guidance on respiratory virus surveillance for the EU/EEA.

This report presents a description of COVID-19 vaccine coverage in the EU/EEA between 1 August 2025 and 27 March 2026, with some variation in reporting